# Qsymia

NDC: 62541-201
Generic name: phentermine and topiramate
Labeler / Manufacturer: Vivus LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20120917

FDA application: NDA022580

## Active ingredients

- PHENTERMINE HYDROCHLORIDE: 3.75 mg/1
- TOPIRAMATE: 23 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62541-201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62541-201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=40dd5602-53da-45ac-bb4b-15789aba40f9
